(18), CRC patients with high expression of six genes, THBS2, FSTL3, TNNT1, BGN, CTHRC1, and NOX4, exhibit shorter overall survival (OS) and shorter recurrence-free survival (RFS). The gene discussed is FSTL3; the disease is colorectal carcinoma.